PHS
BIIB icon

PFM Health Sciences’s Biogen BIIB Stock Holding History

PFM Health Sciences’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-186,635
Closed -$48M – 66
2023
Q3 		$48M Sell
186,635
-11,699
-6% -$3.13M 2.26% 14
2023
Q2 		$56.5M Buy
+198,334
New +$59M 2.19% 13
2023
Q1 		– Sell
-155,659
Closed -$43.1M – 84
2022
Q4 		$43.1M Buy
155,659
+16,333
+12% +$4.61M 1.54% 25
2022
Q3 		$37.2M Buy
+139,326
New +$29.6M 1.35% 34
2021
Q4 		– Sell
-16,900
Closed -$4.78M – 75
2021
Q3 		$4.78M Sell
16,900
-115,372
-87% -$37.8M 0.14% 75
2021
Q2 		$45.8M Buy
132,272
+30,238
+30% +$9.16M 1.44% 28
2021
Q1 		$28.5M Sell
102,034
-12,570
-11% -$3.39M 0.87% 48
2020
Q4 		$28.1M Buy
114,604
+24,888
+28% +$6.42M 0.99% 39
2020
Q3 		$25.5M Buy
+89,716
New +$25M 1.18% 34
2020
Q2 		– Sell
-81,013
Closed -$25.6M – 80
2020
Q1 		$25.6M Sell
81,013
-147,315
-65% -$44.7M 2.11% 20
2019
Q4 		$67.8M Buy
+228,328
New +$63.4M 3.23% 8
2017
Q3 		– Sell
-4,046
Closed -$1.1M – 91
2017
Q2 		$1.1M Sell
4,046
-386,618
-99% -$102M 0.03% 89
2017
Q1 		$107M Sell
390,664
-195,046
-33% -$55.1M 2.67% 5
2016
Q4 		$166M Sell
585,710
-5,141
-0.9% -$1.52M 4.68% 2
2016
Q3 		$185M Buy
590,851
+255,561
+76% +$75.7M 5.41% 1
2016
Q2 		$81.1M Buy
+335,290
New +$88.4M 2.45% 10
2013
Q3 		– Sell
-96,017
Closed -$20.7M – 76
2013
Q2 		$20.7M Buy
+96,017
New +$20.5M 0.43% 49

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PFM Health Sciences's BIIB Position: Q4 2023 in Review

PFM Health Sciences sold out of Biogen (BIIB) in Q4 2023, closing a stake of 186,635 shares — an estimated $48M sold.

PFM Health Sciences first reported a position in BIIB in Q2 2013 and held it in 17 quarters. The position peaked at $185M in Q3 2016. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • PFM Health Sciences reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • PFM Health Sciences sold 186,635 Biogen shares in Q4 2023, an estimated $48M.
  • PFM Health Sciences first reported a position in Biogen in Q2 2013 and held it in 17 quarters.
  • PFM Health Sciences's Biogen position peaked at $185M in Q3 2016.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on PFM Health Sciences's 13F filing for Q4 2023, filed 14 Feb 2024.